Founded in 1995, Rational Therapeutics is a pioneering cancer research laboratory specializing in personalized cancer care. The results of our Ex-Vivo Analysis Programmed Cell Death (EVA-PCD) platform create a functional profile of a tumor’s sensitivity and resistance to various drugs and combinations. With this profile, an oncologist is equipped with the most accurate information to treat an individual’s cancer. Founder, Robert A. Nagourney, MD, an oncologist and hematologist, began researching cancer’s biology more than 25 years ago. His goal is to predict which treatments work best with the least toxicity to patients. Through his innovations, he has pioneered the art and science of personalized cancer care. To learn more, visit www.rational-t.com or Facebook and twitter @RobertNagourney. Also view The Future of Cancer Research Lies Behind Us, a TED talk by Dr. Nagourney here http://bit.ly/qKO0go.